Publications

5808 Results

Adriamycin combinations in advanced breast cancer.

Authors
BL Tranum;T Thigpen;C Vaughn;H Wilson;T Maloney;J Costanzi;J Bickers;N Gad-el-Mawla;R Palmer;B Hoogstraten;L Heilbrun;S Rasmussen
Journal / Conference
Cancer 49: 835-839
Year
1982
Research Committee(s)
Breast

Combination chemotherapy (CMFVP) versus L-Phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: A Southwest Oncology Group study

Authors
H Glucksberg;SE Rivkin;S Rasmussen;B Tranum;N Gad-el-Mawla;J Costanzi;B Hoogstraten;J Athens;T Maloney;J McCracken;C Vaughn
Journal / Conference
Cancer 50:423-434
Year
1982
Research Committee(s)
Breast
Study Number(s)
SWOG-7436

Tamoxifen and oophorectomy in the treatment of recurrent breast cancer A Southwest Oncology Group study

Authors
B Hoogstraten;WS Fletcher;N Gad-el-Mawla;T Maloney;SJ Altman;C Vaughn;MA Foulkes
Journal / Conference
Cancer Res 42: 4788-4791
Year
1982
Research Committee(s)
Breast
Study Number(s)
SWOG-7632

Phase II evaluation of Gallium Nitrate in breast cancer: A Southwest Oncology Group study

Authors
CJ Fabian;LH Baker;CB Vaughn;HE Hynes
Journal / Conference
Cancer Treat Rep 66:1591
Year
1982
Research Committee(s)
Breast
Study Number(s)
SWOG-7917

Adjuvant chemotherapy for operable breast cancer with positive axillary nodes

Authors
S Rivkin;H Glucksberg;M Foulkes
Journal / Conference
ASCO #C-285
Year
1982
Research Committee(s)
Breast
Study Number(s)
SWOG-7436

Phase II evaluation of VP-16-213 in patients with advanced breast cancer

Authors
CB Vaughn
Journal / Conference
Oncology Digest 5-6
Year
1982
Research Committee(s)
Breast
Study Number(s)
SWOG-7514

The role of Tamoxifen in predicting response to ovarian ablation in patients with recurrent breast cancer

Authors
B Hoogstraten
Journal / Conference
ASCO #C-275
Year
1982
Research Committee(s)
Breast
Study Number(s)
SWOG-7632

Adjuvant chemotherapy and hormonal therapy for operable breast cancer with positive axillary nodes

Authors
A Cruz;S Rivkin;WA Knight;R McDivitt;D Tesh;M Foulkes;JB Aust
Journal / Conference
ASCO #C-317
Year
1982
Research Committee(s)
Breast
Study Number(s)
SWOG-7827

Phase II trial of dihydroxyanthracenedione (DHAD, Breast Mitoxantrone) in breast cancer: A Southwest Oncology Group study

Authors
WA Knight III;DD Von Hoff;B Tranum;R O'Bryan
Journal / Conference
ASCO #C-335
Year
1982
Research Committee(s)
Breast
Study Number(s)
SWOG-8008

Adriamycin-containing chemotherapy as a determinant of response in estrogen-receptor negative disseminated breast cancer

Authors
RB Livingston;RP Pugh
Journal / Conference
AACR #595
Year
1982
Research Committee(s)
Breast
Study Number(s)
SWOG-8076